Maury Harden, NP
Women's Health · Mobile, ALNPI 1366157976
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $780 of the $874 with a category attached, or 89.2%. It is spread thinly across 19 manufacturers, the largest accounting for just 17.2% — the pattern of someone who eats at a lot of different presentations.
Across 43 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$150
- Mayne Pharma Commercial LLC$103
- Sumitomo Pharma America, Inc.$87
- Millicent US Inc$59
- Sage Therapeutics, LLC$57
- Shield Therapeutics Inc$56
- plus $362 from 13 others
What the payments were for
- Food & beverage$78089%
- Education$9411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 3 | $150 |
| Mayne Pharma Commercial LLC | 7 | $103 |
| Sumitomo Pharma America, Inc. | 4 | $87 |
| Millicent US Inc | 3 | $59 |
| Sage Therapeutics, LLC | 3 | $57 |
| Shield Therapeutics Inc | 3 | $56 |
| Baxter Healthcare | 2 | $53 |
| Organon | 2 | $45 |
| Pfizer | 2 | $36 |
| Hologic Sales And Service, LLC | 2 | $35 |
| Bayer | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Evofem Biosciences, Inc. | 3 | $27 |
| Bausch Health US, LLC | 1 | $21 |
| AbbVie | 1 | $20 |
| Vapotherm Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Myriad Women's Health, Inc. | 1 | $15 |
How this compares
$874 in reported general payments places this provider in the 60th percentile of 107 women's health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 29 | $17,574 |
| MyrbetriqMirabegron | 11 | $6,995 |
| PremarinEstrogens, Conjugated | 22 | $6,245 |
| Estradiol | 74 | $4,726 |
| Estradiol (Twice Weekly)Estradiol | 11 | $882 |
| Fluconazole | 52 | $420 |
| Clobetasol Propionate | 11 | $410 |
| ValacyclovirValacyclovir Hcl | 11 | $392 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $383 |
| Metronidazole | 21 | $269 |
| Oxybutynin Chloride | 18 | $205 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $87 | $17,57429 claims |
| Astellas Pharma US IncMyrbetriq | $150 | $6,99511 claims |
| PfizerPremarin | $36 | $6,24522 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 107 women's health providers in Alabama.
Other women's health in Mobile
- Mary MatteiMobile$10K
- Leigh MinchewMobile$3K
- Carolyn O'DellMobile$1K
- Ruth KennedyMobile$1K
- Bailey MolseyMobile$465
- Candyce SeymourMobile$381
- Ava MurphyMobile$351
- Mary WigginsMobile$300
- Ashton TureaudBirmingham$26K
- Kathryn LyleBirmingham$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.